GAMMA-INTERFERON TREATMENT INHIBITS COLLAGEN DEPOSITION IN MURINE SCHISTOSOMIASIS
GAMMA-INTERFERON TREATMENT INHIBITS COLLAGEN DEPOSITION IN MURINE SCHISTOSOMIASIS
复制标题
DOI:
10.1002/hep.1840100508
复制
发表时间:
1989-11-01
期刊:
影响因子:
13.5
通讯作者:
ZERN, MA
中科院分区:
文献类型:
--
作者:
CZAJA, MJ;WEINER, FR;ZERN, MA
Since interferons have been shown to affect the synthesis of matrix proteins such as collagen in several in vitro system, the potential role of .gamma.-interferon in inhibiting hepatic fibrosis was investigated. Hepatic cells, consisting primarily of hepatocytes, were treated with recombinant .gamma.-interferon for 24 hr. Northern blot hybridization showed that .gamma.-interferon treatment caused a profound decrease in pro-.alpha.2(I)collagen mRNA levels but an increase in .beta.-actin mRNA content. The effects of .gamma.-interferon were then studied in an in vivo model of hepatic fibrogenesis, murine schistosomiasis. Schistosoma-infected mice were treated with daily i.m. injections of .gamma.-interferon for a 4-week period starting 4 weeks after the initial infection. .gamma.-Interferon treatment decreased collagen deposition as determined by histologic evaluation and measurement of total liver collagen content. Northern blots showed Types I and III procollagen mRNA levels for treated, infected animals to be only 32 and 29% that of infected controls, but .beta.-actin mRNA levels were significantly elevated. These results indicate a potential role for .gamma.-interferon as an antifibrogenic agent in vivo.